This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Find effective wealth accumulation strategies designed specifically for young professionals. Start building your financial future today.
17,961 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Posh just raised $37 million in a Series B to turn the elusive 'what are we doing tonight?' into real activities. The...
Sunoco LP is redefining its business, shifting from fueling pumps to a broader energy platform. With 2026 EBITDA guid...
Morgan Stanley files an amended S-1 for MSBT, signaling a concerted push to launch a spot Bitcoin ETF and disrupt the...
Many pre-retirees dream of a stress-free retirement funded mainly by Social Security. The reality is more complex. Th...
Snowflake has slid this year even as its data cloud strategy gains momentum. This guide breaks down whether the pullb...
Adobe is turning finance into an AI-powered operation, auto-responding 300,000 emails and halving contract-review tim...
March's trading session brought a noticeable shift as airline stocks rallied amid easing fuel concerns. This piece br...
As bond yields drift, investors are eyeing dividend ETFs that could replace bond income in 2026. Learn how three top ...
In 2026, three popular tech ETFs tell three different stories about how to own technology: FTEC offers broad exposure...
A pivotal FDA decision sent Corcept Therapeutics stock soaring. This guide explains the news, what it could mean for ...
AppLovin exposes investors to a volatile mix of ad spend cycles and AI disruption fears. This guide breaks down the d...